US Patent 11473123 Morphinan compounds
Patent 11473123 was granted and assigned to Concert Pharmaceuticals on October, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11473123 Morphinan compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.